Results 161 to 170 of about 2,627 (188)
Some of the next articles are maybe not open access.
Summary of opinion: Miglustat Dipharma,miglustat
Case Medical Research, 2018openaire +2 more sources
Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)
Canadian Journal of Health TechnologiesReimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the exception ...
openaire +1 more source
Miglustat. Oxford GlycoSciences/Actelion.
Current opinion in investigational drugs (London, England : 2000), 2003Oxford GlycoSciences and Actelion have developed and launched miglustat (OGT-918; Vevesca; Zavesca) for the treatment of type 1 Gaucher disease. Miglustat is an orally administered small-molecule glucosylceramide glucosyltransferase inhibitor licensed from Searle, and it is also in development for the treatment of other glycolipid storage disorders ...
openaire +1 more source
Miglustat has no apparent effect on spermatogenesis in normal men.
Human Reproduction, 2007John K Amory +2 more
exaly
Miglustat: A Review of Its Use in Niemann-Pick Disease Type C
Drugs, 2013Katherine A Lyseng-Williamson
exaly